Ledger.Open graph →
SEC Form D · filed May 6, 2021

Cambrian BioPharma Inc

Offering
$28.4M
Sold
$28.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Maryanna G. Saenko · New York, NYDirectorJames G. Peyer · New York, NYExec · Director · PromoterTravis Kell · Santa Monica, CAExec · Director · PromoterAnton Zietsman · Santa Monica, CADirectorChristian G. Angermeyer · Brooklyn, NYDirectorJeffery C. Schneider · MOORESTOWN, NJExec · Director · PromoterRobert S. Newell · Las Vegas, NVDirectorChristian G. Angermeyer · Brooklyn, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗